Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
12 2022
Historique:
received: 05 04 2022
accepted: 02 09 2022
revised: 31 08 2022
pubmed: 22 9 2022
medline: 22 12 2022
entrez: 21 9 2022
Statut: ppublish

Résumé

Polygenic risk prediction remains an important aim of genetic association studies. Currently, the predictive power of schizophrenia polygenic risk scores (PRSs) is not large enough to allow highly accurate discrimination between cases and controls and thus is not adequate for clinical integration. Since PRSs are rarely used to reveal biological functions or to validate candidate pathways, to fill this gap, we investigated whether their predictive ability could be improved by building genome-wide (GW-PRSs) and pathway-specific PRSs, using distance- or expression quantitative trait loci (eQTLs)- based mapping between genetic variants and genes. We focused on five pathways (glutamate, oxidative stress, GABA/interneurons, neuroimmune/neuroinflammation and myelin) which belong to a critical hub of schizophrenia pathophysiology, centred on redox dysregulation/oxidative stress. Analyses were first performed in the Lausanne Treatment and Early Intervention in Psychosis Program (TIPP) study (n = 340, cases/controls: 208/132), a sample of first-episode of psychosis patients and matched controls, and then validated in an independent study, the epidemiological and longitudinal intervention program of First-Episode Psychosis in Cantabria (PAFIP) (n = 352, 224/128). Our results highlighted two main findings. First, GW-PRSs for schizophrenia were significantly associated with early psychosis status. Second, oxidative stress was the only significantly associated pathway that showed an enrichment in both the TIPP (p = 0.03) and PAFIP samples (p = 0.002), and exclusively when gene-variant linking was done using eQTLs. The results suggest that the predictive accuracy of polygenic risk scores could be improved with the inclusion of information from functional annotations, and through a focus on specific pathways, emphasizing the need to build and study functionally informed risk scores.

Identifiants

pubmed: 36131045
doi: 10.1038/s41380-022-01779-1
pii: 10.1038/s41380-022-01779-1
pmc: PMC9763118
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5135-5143

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L011794/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Nature. 2009 Aug 6;460(7256):744-7
pubmed: 19571808
Front Genet. 2020 May 13;11:424
pubmed: 32477401
JAMA Psychiatry. 2022 Mar 01;79(3):260-269
pubmed: 35019943
Early Interv Psychiatry. 2008 Aug;2(3):178-87
pubmed: 21352151
Bioinformatics. 2014 May 1;30(9):1266-72
pubmed: 24413527
Transl Psychiatry. 2018 Oct 12;8(1):220
pubmed: 30315150
Mol Psychiatry. 2020 Nov;25(11):2889-2904
pubmed: 30911107
Biopreserv Biobank. 2015 Oct;13(5):311-9
pubmed: 26484571
Eur Arch Psychiatry Clin Neurosci. 1999;249(4):174-9
pubmed: 10449592
Trends Neurosci. 2012 Jan;35(1):57-67
pubmed: 22154068
Nat Genet. 2016 May;48(5):481-7
pubmed: 27019110
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12495-12500
pubmed: 30455310
BMC Genet. 2019 Nov 12;20(1):85
pubmed: 31718536
Early Interv Psychiatry. 2013 Aug;7(3):322-8
pubmed: 23445318
Nat Genet. 2023 Mar;55(3):377-388
pubmed: 36823318
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Curr Opin Neurobiol. 2009 Apr;19(2):220-30
pubmed: 19481443
Biol Psychiatry. 2017 Mar 15;81(6):470-477
pubmed: 27765268
Gigascience. 2019 Jul 1;8(7):
pubmed: 31307061
Transl Psychiatry. 2016 Jul 26;6(7):e859
pubmed: 27459724
Nat Genet. 2022 Jan;54(1):30-39
pubmed: 34931067
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Transl Psychiatry. 2019 Sep 2;9(1):212
pubmed: 31477688
Nat Rev Neurosci. 2016 Feb;17(2):125-34
pubmed: 26763624
Prog Neurobiol. 2011 Jan;93(1):13-24
pubmed: 20950668
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
JAMA Psychiatry. 2018 Jun 1;75(6):555-565
pubmed: 29800949
Pharmacol Ther. 2020 Jan;205:107426
pubmed: 31629007
Nat Neurosci. 2019 Mar;22(3):374-385
pubmed: 30718903
Schizophr Bull. 2018 Feb 15;44(2):317-327
pubmed: 29462456
Cell. 2013 Mar 14;152(6):1237-51
pubmed: 23498934
Am J Psychiatry. 2019 Oct 1;176(10):846-855
pubmed: 31416338
PLoS Med. 2005 May;2(5):e141
pubmed: 15916472
Biol Psychiatry. 2021 Jan 1;89(1):41-53
pubmed: 32736792
Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43
pubmed: 22938092
Mol Psychiatry. 2018 Oct;23(10):2057-2065
pubmed: 29180672
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Mol Psychiatry. 2015 Jul;20(7):827-38
pubmed: 25155877
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Biol Psychiatry. 2018 Mar 15;83(6):492-498
pubmed: 28987712
Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71
pubmed: 16343296
Nature. 2016 Feb 11;530(7589):177-83
pubmed: 26814963
Mol Psychiatry. 2022 Apr;27(4):1886-1897
pubmed: 34759358
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Am J Psychiatry. 2020 Dec 1;177(12):1119-1128
pubmed: 33256439
Mol Psychiatry. 2017 Jul;22(7):936-943
pubmed: 28322275
BMC Bioinformatics. 2011 Mar 08;12:68
pubmed: 21385424
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Genet. 2008 Sep;40(9):1053-5
pubmed: 18677311
Int J Neuropsychopharmacol. 2019 Jul 1;22(7):445-448
pubmed: 31139821
Nat Med. 2021 Sep;27(9):1576-1581
pubmed: 34489608
Neuropsychopharmacology. 2008 Aug;33(9):2187-99
pubmed: 18004285
Genet Epidemiol. 2012 Apr;36(3):214-24
pubmed: 22714935
Schizophr Res. 2016 Sep;176(1):41-51
pubmed: 25000913
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
Br J Psychiatry. 2013 Jul;203(1):58-64
pubmed: 23703317
J Psychopharmacol. 2015 Feb;29(2):97-115
pubmed: 25586400
Mol Psychiatry. 2022 Feb;27(2):1192-1204
pubmed: 34686767
Schizophr Bull. 2013 Nov;39(6):1174-9
pubmed: 24072812
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
PLoS Genet. 2010 Apr 01;6(4):e1000888
pubmed: 20369019

Auteurs

Giorgio Pistis (G)

Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Lausanne, Switzerland. giorgio.pistis@chuv.ch.

Javier Vázquez-Bourgon (J)

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Department of Psychiatry, University Hospital Marqués de Valdecilla, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, Spain.
Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain.

Margot Fournier (M)

Unit for Research in Schizophrenia, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), Prilly, Lausanne, Switzerland.

Raoul Jenni (R)

Unit for Research in Schizophrenia, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), Prilly, Lausanne, Switzerland.

Martine Cleusix (M)

Unit for Research in Schizophrenia, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), Prilly, Lausanne, Switzerland.

Sergi Papiol (S)

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Sophie E Smart (SE)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

Antonio F Pardiñas (AF)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

James T R Walters (JTR)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.

James H MacCabe (JH)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Zoltán Kutalik (Z)

University Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.
Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Philippe Conus (P)

Service of General Psychiatry, Department of Psychiatry, University Hospital Center and University of Lausanne, Prilly, Lausanne, Switzerland.

Benedicto Crespo-Facorro (B)

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (IBiS)-CSIC, University of Seville, First-episode Psychosis Research Network of Andalusia (Red PEPSur), Seville, Spain.

Kim Q Do (K)

Unit for Research in Schizophrenia, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital (CHUV), Prilly, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH